0 CHECKOUT

Pouchitis - Pipeline Review, Q4 2010

  • ID: 1464267
  • December 2010
  • 20 pages
  • Global Markets Direct

Pouchitis - Pipeline Review, Q4 2010

Summary

Global Markets Direct’s, “Pouchitis Pipeline Review, Q4 2010”, provides an overview of the Pouchitis therapeutic pipeline. This report provides information on the therapeutic development for Pouchitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Pouchitis. “Pouchitis-Pipeline Review 2010, Q4 2010” is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- A snapshot of the global therapeutic scenario for Pouchitis.
- A review of the Pouchitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- READ MORE >

Note: Product cover images may vary from those shown



List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Pouchitis Overview
Therapeutics Development
An Overview of Pipeline Products for Pouchitis
Pouchitis Therapeutics under Development by Companies
Companies Involved in Pouchitis Therapeutics Development
Ocera Therapeutics, Inc.
Atlantic Pharmaceuticals, Inc.
AesRx, LLC.
Pouchitis Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Pfizer, Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S